Skip to content

Skin Conditioning

NONAPEPTIDE-37

65

Safety score · 0–100

Fine

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A synthetic nine-amino-acid peptide used as a skin-conditioning active. Low-risk by class; specific evidence is thin.

Nonapeptide-37 is a defined-sequence synthetic nine-amino-acid peptide used as a skin-conditioning agent. Nonapeptides remain in the low-permeation, rapid-degradation regime characteristic of short cosmetic peptides, supporting a favorable class safety profile. No CIR or SCCS opinion exists. Independent peer-reviewed efficacy data is essentially absent; claims rely on supplier in vitro work.

Function

SKIN CONDITIONING

Skin benefits

  • Skin conditioning
  • Low irritation
  • Defined synthetic sequence

Known concerns

  • Limited independent data
  • No regulatory review
  • Supplier-driven claims

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related skin conditionings

65
(ANGELICA GIGAS/CNIDIUM OFFICINALE/PAEONIA LACTIFLORA) ROOT EXTRACT
Skin Conditioning
 65
(SH-OLIGOPEPTIDE-78 S-FRUIT FLY OLIGOPEPTIDE-1) PEPTIDES
Skin Conditioning
 65
(SH-PENTAPEPTIDE-10 6-AMINOCAPROOYL SH-PENTAPEPTIDE-11) SP
Skin Conditioning
 65
ABELMOSCHUS MANIHOT CALLUS EXTRACELLULAR VESICLES
Skin Conditioning
 65
ABIES BALSAMEA EXTRACT
Skin Conditioning
 65
ACEFYLLINE METHYLSILANOL MANNURONATE
Skin Conditioning
 65
ACETAMINO METHYLSULFONYLBUTYROYL DIPEPTIDE-57
Skin Conditioning
 65
ACETYL HEPTAPEPTIDE-69
Skin Conditioning

Check your shelf

Find NONAPEPTIDE-37 in your products.

Scan any cosmetic product with LuxSense to see if it contains NONAPEPTIDE-37 and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.